eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | rheumatoid arthritis |
| Comorbidity | C0042373|vascular disease |
| Sentences | 67 |
| PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24498229 | Objective: to evaluate the risk of cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids. |
| PubMedID- 24268008 | Cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 24511540 | For instance, angiopoietin-2 (angpt-2), a marker of endothelial cell activation, has been proposed as a mediator of angiogenesis, which might play an important role in the regulation of endothelial integrity and inflammation and thus is related to severity and cardiovascular disease in patients with rheumatoid arthritis [2]. |
| PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
| PubMedID- 23256829 | Traditional cardiovascular risk factors only partly explain increased risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
| PubMedID- 23848174 | Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by koivuniemi et al. |
| PubMedID- 21608334 | Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis. |
| PubMedID- 26362702 | Objective: to identify risk factors for cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 22927710 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 23193471 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. |
| PubMedID- 21276397 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 25969671 | Several epidemiological studies reported increased morbidity and mortality from cardiovascular diseases in patients with rheumatoid arthritis [2], and strong evidences from basic research and epidemiological studies support that inflammation and venous thrombosis are associated processes [3]. |
| PubMedID- 23244227 | Objectives: to study cardiovascular autopsy findings and the lifetime prevalence of cardiovascular diseases (cvds) in patients with rheumatoid arthritis (ra). |
| PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
| PubMedID- 23749610 | Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. |
| PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
| PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
| PubMedID- 25011482 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
| PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21073447 | To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed. |
| PubMedID- 21981268 | Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score [frs]). |
| PubMedID- 22360682 | Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
| PubMedID- 20827876 | Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
| PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24361194 | Usefulness of the ankle-brachial index as a survey method for subclinical vascular disease in patients with rheumatoid arthritis. |
| PubMedID- 26082375 | [pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 20735865 | Palomino-morales and colleagues [1] report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
| PubMedID- 21520672 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
| PubMedID- 20842919 | [cardiovascular diseases in rheumatoid arthritis]. |
| PubMedID- 21388351 | Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 23899926 | Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 22161801 | Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis. |
| PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20383550 | Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 20638217 | Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice. |
| PubMedID- 26023546 | Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 20164773 | Cardiovascular disease in rheumatoid arthritis: a step forward. |
| PubMedID- 22513132 | The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized [1-4]. |
| PubMedID- 22249350 | Risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
Page: 1 2